Uytun, S. Et Al. 2022. One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?. EUROPEAN RESPIRATORY JOURNAL .

Uytun, S., Polat, S. E., Tabakci, S. O., Cinel, G., EMİRALİOĞLU ORDUKAYA, N., Yalcin, E., ... Kiper, N.(2022). One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?. EUROPEAN RESPIRATORY JOURNAL .

Uytun, S. Et Al. "One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?," EUROPEAN RESPIRATORY JOURNAL , 2022

Uytun, S. Et Al. "One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?." EUROPEAN RESPIRATORY JOURNAL , 2022

Uytun, S. Et Al. (2022) . "One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?." EUROPEAN RESPIRATORY JOURNAL .

@article{article, author={S. Uytun Et Al. }, title={One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?}, journal={EUROPEAN RESPIRATORY JOURNAL}, year=2022}